Postdoctoral position in mathematical statistics at University of Liege

Highlights:
  1. HEC Management School at University of Liège (HEC-ULg) invites applications for a one year (possibly renewable) full time post-doctoral research position starting on October 1st, 2010.
  2. Prerequisites for qualification are a Ph.D. in Statistics or in a related field. The candidate should demonstrate excellent research potential with significant international exposure. The School is especially interested in candidates with a background in the areas of mathematical statistics, nonparametrics, survival analysis, Bayesian or robust statistics with a special attention for practical applications. A limited teaching duty (in English or French) is possible (e.g. a short course on the candidate area of research), and participation in various scientific activities (Graduate School in Statistics and Actuarial Sciences, local seminarsâ) is expected.



Ph.D Positions in Social Sciences, Netherlands 2010

Highlights:
  1. The ICS selection procedure for 12 Ph.D positions at the ICS starts March 25, 2010.
  2. The deadline for applications is May 1, 2010.
  • The only way in which you can apply is by using our electronic application form.
  • Please note that the application form has to be filled in in English.
  • You will be asked in the application for which of the Ph.D projects you wish to apply.
  • Please note that in addition you can propose your own research (in the format of the ICS proposals). This research project should be related to one of the ICS research themes for which Ph.D projects are offered.


Post-Doctoral Position in drug discovery

Highlights:
1.      BIOALVO, a global biotech company acting on the early stages of drug discovery and development with headquarters in Lisbon, Portugal, offers a Post-Doctoral Position within the scope of the FP7-funded project entitled  “α-synuclein and Tau: dangerous liaisons”.
2.      Although classically considered as distinct pathological entities, recent emerging evidence is revealing a number of pathological and clinical features with consistent overlapping between synucleinopathies and tauopathies, suggesting a mechanistic link between these disorders. The project is to clarify the synergistic effect of α-synuclein and tau interaction in the neurodegenerative process and to identify compounds that modulate that synergy.
3.      We will take advantage of the power of yeast genetics in order to perform a genome wide screening to identify genes that modulate the toxic phenotype caused by the concomitant expression of tau and α-synuclein. We want to identify cellular targets of future therapeutic intervention in order to generate a yeast-based drug discovery platform for the screening of compounds with the potential to ameliorate diseases associated with tau and/or synuclein.

Recent Post

Enter your email address:

Delivered by FeedBurner